North America Leads the Radiation Toxicity Therapeutics Market Amid Rising Cancer Incidence
North America has established itself as the dominant region in the global Radiation Toxicity Therapeutics Market, driven by high cancer incidence, advanced healthcare infrastructure, and significant investment in oncology research. The region accounted for a substantial share in 2024, valued at approximately USD 754 million, and is projected to reach USD 1.39 billion by 2035. The region's...
0 Reacties 0 aandelen 3 Views 0 voorbeeld